SOUTH SAN FRANCISCO, Calif. – Feb. 24, 2015 – Fluidigm Corporation (NASDAQ:FLDM) today announced that Chief Executive Officer and President Gajus Worthington will make overview remarks and participate in a Q&A session at the 35th Annual Cowen & Company Health Care Conference in Boston on Tuesday,

FLUIDIGM DEBUTS NEWEST STATE-OF-THE-ART SINGLE-CELL SYSTEM AT AGBT   Fluidigm’s New PolarisTM System Integrates Cell Physiology and Molecular Biology into a Single Workflow   SOUTH SAN FRANCISCO, Calif., Feb. 19, 2015 – Fluidigm Corporation (NASDAQ:FLDM) will provide attendees at the 16th annual

Features Complete Set of Fluidigm Single-Cell Technologies SOUTH SAN FRANCISCO, Calif., Feb. 5, 2015 – Fluidigm Corporation (NASDAQ:FLDM) today announced that Science for Life Laboratory (SciLifeLab) has established the Swedish National Center for Single-Cell Biology.

2014 organic revenue growth of 35% year-over-year

SOUTH SAN FRANCISCO, Calif., Jan. 27, 2014 — Fluidigm Corporation (NASDAQ:FLDM) will report its fourth quarter and 2014 full year financial results on February 5, 2015, after close of market.   Gajus Worthington, Fluidigm president and chief executive officer, and Vikram Jog, chief financial

And Issues 2015 Revenue Guidance

Gajus Worthington will present at the 33rd Annual J.P. Morgan Healthcare Conference

New C1 Application Enables Researchers to Discover Genetic Signatures

Piper Jaffray Healthcare Conference 2014 SOUTH SAN FRANCISCO, Calif.--( BUSINESS WIRE )--Fluidigm Corporation (NASDAQ:FLDM) today announced that Chief Financial Officer Vikram Jog and Director of Investor Relations and Strategy Ana Petrovic will make overview remarks and participate in a Q&A

C1&#8482 System Enhancements Define a New Benchmark for Single-Cell Discovery